Hypertrophic Cardiomyopathy, Sudden Death and Implantable Defibrillators

نویسندگان

چکیده

Implantable cardiac defibrillators (ICD) are greatly efficient in eliminating arrhythmias patients withhigh-risk hypertrophic cardiomyopathy, showing that this equipment has a contribution the prevention and treatment of unexpected death. When have risk marker, death one or more first-degree relations with maximal left ventricle wall thickness 30 mm current unexplained syncopal episode, ICD installation is considered appropriate. If dangerously fast heartbeat prevents heart from pumping enough blood to rest body ventricular fibrillationor tachycardia, if patient at high suffering such rhythm problem (arrhythmia), usually due weak muscle, can survive using ICD.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

CONTEXT Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved. OBJECTIVE To study the relationship between clinical risk profile and incidence and efficacy of ICD intervention in HCM. DESIGN, SE...

متن کامل

Implantable defibrillators and sudden cardiac death.

Sudden cardiac death (SCD) is among the most common causes of death in developed countries throughout the world. It is estimated that more than 3 million people die yearly from SCD, with a survival rate of less than 1%. In the United States, the Center for Disease Control recently estimated an annual incidence of 450 000 sudden deaths,1 with a survival rate of approximately 5%, although this pr...

متن کامل

Sudden cardiac death and implantable cardioverter-defibrillators.

Sudden cardiac death is a major public health problem, affecting 500,000 patients in the United States annually. An implantable cardioverter-defibrillator (ICD) can terminate malignant ventricular arrhythmias and has been shown to improve survival in high-risk populations. Although sudden cardiac death is a heterogeneous condition, left ventricular ejection fraction of 35 percent or less remain...

متن کامل

Prevention of Sudden Death in Hypertrophic Cardiomyopathy

C ase presentation: A 14-yearold girl died suddenly and unexpectedly while exercising. Clinical and echocardiographic family screening identified hypertrophic cardiomyopathy (HCM) in her only sibling, an asymptomatic 17-year-old boy. In her brother, echocardiography showed extreme septal ventricular hypertrophy, 35 mm in thickness; left ventricular (LV) outflow obstruction was absent. Left atri...

متن کامل

Sudden cardiac death risk in hypertrophic cardiomyopathy.

It is well recognized that sudden cardiac death (SCD) is an infrequent, unpredictable, but catastrophic complication of hypertrophic cardiomyopathy (HCM). In population-based studies the overall SCD rate is 1% per year among patients with a clinical diagnosis of HCM. A crucial aspect of the management of patients with HCM is an assessment of each individual patient’s risk for SCD so that preven...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: RA journal of applied research

سال: 2022

ISSN: ['2394-6709']

DOI: https://doi.org/10.47191/rajar/v8i1.09